Cite
HARVARD Citation
Narita, Y. et al. (2021). Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial. Cancer science. 112 (12), pp. 5020-5033. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Narita, Y. et al. (2021). Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial. Cancer science. 112 (12), pp. 5020-5033. [Online].